2000
DOI: 10.1016/s0014-2999(00)00005-4
|View full text |Cite
|
Sign up to set email alerts
|

Presynaptic nicotinic receptors modulating dopamine release in the rat striatum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

14
163
1

Year Published

2001
2001
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 209 publications
(178 citation statements)
references
References 28 publications
14
163
1
Order By: Relevance
“…It is also possible that a component of either or both the behavioral and dopamine effects could be indirect via activity at acetylcholine receptors on NAc glutamate terminals. Indeed, cholinergic modulation of striatal dopamine release has been demonstrated, under some conditions, to be sensitive to glutamate receptor antagonists (Cachope et al, 2012;Wonnacott et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…It is also possible that a component of either or both the behavioral and dopamine effects could be indirect via activity at acetylcholine receptors on NAc glutamate terminals. Indeed, cholinergic modulation of striatal dopamine release has been demonstrated, under some conditions, to be sensitive to glutamate receptor antagonists (Cachope et al, 2012;Wonnacott et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…In this study, we identified reduced Chrnα6 expression in ak striata. α6-subunit containing nicotinic receptors are selectively expressed on dopaminergic terminals in the striatum (Wonnacott et al, 2000;Zoli et al, 2002). Therefore, it is possible that reduced Chrnα6 expression reflects a presynaptic striatal alteration due to the failure of dorsal striatonigral afferents to develop in these mice (Nunes et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Present data do not allow any definitive conclusion regarding the mechanism behind the inhibitory action of clozapine on VTA DA neurons. Hypothetically, the effect could be mediated by (I) activation of presynaptic a7* nicotinic receptors located on glutamatergic afferents (McGehee et al, 1995;Wonnacott et al, 2000; leading to a potentially increased glutamate release by clozapine) (II) activation of postsynaptic a7* nicotinic receptor, located on cell soma or dendrites of VTA DA neurons or (III) displacement of KYNA at postsynaptic NMDA receptors located on cell soma or dendrites of GABAergic neurons projecting to VTA DA neurons, thereby restoring the balance between GABAergic and glutamatergic projections to the VTA. An interaction between clozapine and the a7* nicotinic receptor is supported by the demonstration of a clozapine-induced release of acetylcholine in the prefrontal cortex (Ichikawa et al, 2002).…”
Section: Discussionmentioning
confidence: 99%